1,725
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Metabolic characteristics of large and small extracellular vesicles from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy

, , , , , , , , , , , , , , , & show all
Article: 1790158 | Received 31 Jul 2019, Accepted 18 Jun 2020, Published online: 14 Jul 2020

References

  • Porcel JM, Gasol A, Bielsa S, et al. Clinical features and survival of lung cancer patients with pleural effusions. Respirology. 2015;20(4):654–16.
  • Light RW. Update on tuberculous pleural effusion. Respirology. 2010;15(3):451–458.
  • Organization WH. Global Tuberculosis Report 2018. Geneva 2018; WHO 2018 Available at http://www.who.int/tb/publications/global_report/en
  • Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311.
  • Wang F, Wang Z, Tong Z, et al. A pilot study of autofluorescence in the diagnosis of pleural disease. Chest. 2015;147:1395–1400.
  • Porcel JM. Biomarkers in the diagnosis of pleural diseases: a 2018 update. Ther Adv Respir Dis. 2018;12:1753466618808660.
  • Gopi A, Madhavan SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest. 2007;131(3):880–889.
  • Porcel JM. Tuberculous pleural effusion. Lung. 2009;187(5):263–270.
  • Valdés L, Alvarez D, San José E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998;158(18):2017–2021. .
  • Sheridan C. Exosome cancer diagnostic reaches market. Nat Biotechnol. 2016;34(4):359–360.
  • Tompkins AJ, Chatterjee D, Maddox M, et al. The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy. J Extracell Vesicles. 2015;4(1):23815. .
  • Yanez-Mo M, Siljander PR-M, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(1):27066. .
  • Gurunathan S, Kang MH, Jeyaraj M, et al. Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. Cells. 2019;8(4):E307.
  • Exosomes MJ. Ectosomes in Intercellular Communication. Curr Biol. 2018;28(8):R435–R444.
  • Clos-Garcia M, Loizaga-Iriarte A, Zuniga-Garcia P, et al. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression. J Extracell Vesicles. 2018;7(1):1470442. .
  • McKiernan J, Donovan MJ, O’Neill V, et al. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncol. 2016;2(7):882–889. .
  • Wang W, Zhou Q, Zhai K, et al. Diagnostic accuracy of interleukin 27 for tuberculous pleural effusion: two prospective studies and one meta-analysis. Thorax. 2017;73:240–247.
  • Lam CW, Law CY. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions. J Proteome Res. 2014;13(9):4040–4046.
  • Park JO, Choi DY, Choi DS, et al. Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics. 2013;13(14):2125–2134. .
  • Haggadone MD, Peters-Golden M. Microenvironmental Influences on Extracellular Vesicle-Mediated Communication in the Lung. Trends Mol Med. 2018;24(11):963–975.
  • Andre F, Schartz NEC, Movassagh M, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002;360(9329):295–305. .
  • Bard MP, Hegmans JP, Hemmes A, et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol. 2004;31(1):114–121. .
  • Guo M, Wu F, Hu G, et al. Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion. Sci Transl Med. 2019;11(498):474. .
  • Yekula A, Minciacchi VR, Morello M, et al. Large and small extracellular vesicles released by glioma cells in vitro and in vivo. J Extracell Vesicles. 2020;9(1):1689784. .
  • Durcin M, Fleury A, Taillebois E, et al. Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles. J Extracell Vesicles. 2017;6(1):1305677. .
  • Matsumoto A, Takahashi Y, Chang H-Y, et al. Blood concentrations of small extracellular vesicles are determined by a balance between abundant secretion and rapid clearance. J Extracell Vesicles. 2019;9(1):1696517.
  • Vagner T, Spinelli C, Minciacchi VR, et al. Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. J Extracell Vesicles. 2018;7(1):1505403. .
  • Min L, Zhu S, Chen L, et al. Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs. J Extracell Vesicles. 2019;8(1):1643670. .
  • Lazaro-Ibanez E, Lunavat TR, Jang SC, et al. Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines. BMC Cancer. 2017;17(1):92. .
  • Welton JL, Brennan P, Gurney M, et al. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. J Extracell Vesicles. 2016;5(1):31209. .
  • Haraszti RA, Didiot M-C, Sapp E, et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5:32570.
  • Luo P, Yin P, Hua R, et al. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2018;67(2):662–675. .
  • Tian Y, Wang Z, Liu X, et al. Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling. Clin Cancer Res. 2018;24(9):2100–2109. .
  • Kanada M, Bachmann MH, Hardy JW, et al. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A. 2015;112(12):E1433–1442. .
  • Feller-Kopman DJ, Reddy CB, DeCamp MM, et al. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(7):839–849. .
  • Palviainen M, Saari H, Karkkainen O, et al. Metabolic signature of extracellular vesicles depends on the cell culture conditions. J Extracell Vesicles. 2019;8(1):1596669. .
  • Chen S, Hoene M, Li J, et al. Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J Chromatogr A. 2013;9:9–16.
  • Xuan Q, Hu C, Yu D, et al. Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography-Mass Spectrometry. Anal Chem. 2018;90(12):7608–7616. .
  • Luo P, Yin P, Zhang W, et al. Optimization of large-scale pseudotargeted metabolomics method based on liquid chromatography–mass spectrometry. J Chromatogr A. 2016;1437:127–136.
  • Chen S, Kong H, Lu X, et al. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry. Anal Chem. 2013;85(17):8326–8333.
  • Smilde AK, van der Werf MJ, Bijlsma S, et al. Fusion of mass spectrometry-based metabolomics data. Anal Chem. 2020;9(20):1696517–1696536.
  • Want EJ, Wilson ID, Gika H, et al. Global metabolic profiling procedures for urine using UPLC–MS. Nat Protoc. 2010;5(6):1005–1018. .
  • Van Deun J, Mestdagh P, Agostinis P, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14(3):228. .
  • Brzozowski JS, Jankowski H, Bond DR, et al. Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines. Lipids Health Dis. 2018;17(1):211. .
  • Puhka M, Takatalo M, Nordberg ME, et al. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes. Theranostics. 2017;7(16):3824–3841. .
  • Achreja A, Zhao H, Yang L, et al. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism. Metab Eng. 2017;43:156–172.
  • Welton JL, Khanna S, Giles PJ, et al. Proteomics Analysis of Bladder Cancer Exosomes. Mol Cell Proteomics. 2010;9(6):1324–1338. .
  • Dunn WB, Broadhurst DI, Atherton HJ, et al. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011;40(1):387–426.
  • German JB, Bauman DE, Burrin DG, et al. Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J Nutr. 2004;134(10):2729–2732. .
  • van der Greef J, Stroobant P. van der Heijden R. The role of analytical sciences in medical systems biology. Curr Opin Chem Biol. 2004;8(5):559–565.
  • Choi DS, Kim DK, Kim YK, et al. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics. 2013;13(10–11):1554–1571.
  • Skotland T, Ekroos K, Kauhanen D, et al. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. Eur J Cancer. 2017;70:122–132.
  • Llorente A, Skotland T, Sylvänne T, et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 2013;1831(7):1302–1309. .
  • Skotland T, Sandvig K, Llorente A. Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res. 2017;66:30–41.
  • Róg T, Orłowski A, Llorente A, et al. Interdigitation of long-chain sphingomyelin induces coupling of membrane leaflets in a cholesterol dependent manner. Biochim Biophys Acta. 2015;1858(2):281–288. .
  • Trajkovic K, Hsu C, Chiantia S, et al. Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes. Science. 2008;29:5867.
  • Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139–150.
  • Almena M, Merida I. Shaping up the membrane: diacylglycerol coordinates spatial orientation of signaling. Trends Biochem Sci. 2011;36(11):593–603.
  • Bogatcheva NV, Sergeeva MG, Dudek SM, et al. Arachidonic acid cascade in endothelial pathobiology. Microvasc Res. 2005;69(3):107–127.
  • Liu J, Mazzone PJ, Cata JP, et al. Serum free fatty acid biomarkers of lung cancer. Chest. 2014;146(3):670–679.
  • Xu R, Greening DW, Rai A, et al. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 2015;87:11–25.
  • Zhao H, Yang L, Baddour J, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016;5:e10250.
  • Eggers LF, Muller J, Marella C, et al. Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema. Sci Rep. 2017;7(1):11087. .
  • Padanad MS, Konstantinidou G, Venkateswaran N, et al. Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis. Cell Rep. 2016;16(6):1614–1628. .
  • Geiger R, Rieckmann JC, Wolf T, et al. L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. Cell. 2016;167(3):829–842 e813. .
  • Shao Y, Ye G, Ren S, et al. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer. Int J Cancer. 2018;143(2):396–407. .
  • Platten M, Wick W, Van den Eynde BJ. Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012;72(21):5435–5440.
  • Mihalik SJ, Goodpaster BH, Kelley DE, et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010;18(9):1695–1700.
  • Nie H, Li J, Yang X-M, et al. Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma. Hepatology. 2015;62(4):1145–1159. .
  • Wang W, Yang J, Zhang J, et al. Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation. Proc Natl Acad Sci U S A. 2018;115(20):5283–5288. .
  • Kachler K, Bailer M, Heim L, et al. Enhanced acid sphingomyelinase activity drives immune evasion and tumor growth in non-small cell lung carcinoma. Cancer Res. 2017;77(21):5963–5976. .
  • Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 1999;9(2):67–81.
  • Caylà JA, Garcia-Zamalloa A, Taboada-Gomez J. Diagnostic Accuracy of Adenosine Deaminase and Lymphocyte Proportion in Pleural Fluid for Tuberculous Pleurisy in Different Prevalence Scenarios. PLoS ONE. 2012;7:e38729.